Global Non-Invasive Prenatal DNA Testing Service Market Growth (Status and Outlook) 2024-2030

Global Non-Invasive Prenatal DNA Testing Service Market Growth (Status and Outlook) 2024-2030

The non-invasive prenatal DNA testing service collects peripheral venous blood from pregnant women, uses the next-generation DNA sequencing technology to sequence the free DNA fragments (including fetal free DNA) in the maternal peripheral plasma, and performs bioinformatics analysis on the sequencing results to obtain the genetic information of the fetus and detect whether the fetus has a chromosomal disease.

The global Non-Invasive Prenatal DNA Testing Service market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “Non-Invasive Prenatal DNA Testing Service Industry Forecast” looks at past sales and reviews total world Non-Invasive Prenatal DNA Testing Service sales in 2022, providing a comprehensive analysis by region and market sector of projected Non-Invasive Prenatal DNA Testing Service sales for 2023 through 2029. With Non-Invasive Prenatal DNA Testing Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-Invasive Prenatal DNA Testing Service industry.

This Insight Report provides a comprehensive analysis of the global Non-Invasive Prenatal DNA Testing Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Non-Invasive Prenatal DNA Testing Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Non-Invasive Prenatal DNA Testing Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-Invasive Prenatal DNA Testing Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-Invasive Prenatal DNA Testing Service.

United States market for Non-Invasive Prenatal DNA Testing Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Non-Invasive Prenatal DNA Testing Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Non-Invasive Prenatal DNA Testing Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Non-Invasive Prenatal DNA Testing Service players cover Natera Inc, Illumina, Roche, GE Healthcare, Thermo Fisher Scientific, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Non-Invasive Prenatal DNA Testing Service market by product type, application, key players and key regions and countries.

Segmentation by Type:
Serum Biochemical Index Detection
Maternal Peripheral Blood Free DNA Detection
Ultrasound Screening

Segmentation by Application:
Hospitals
Medical Institutions
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Serum Biochemical Index Detection
Maternal Peripheral Blood Free DNA Detection
Ultrasound Screening

Segmentation by Application:
Hospitals
Medical Institutions
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Natera Inc
Illumina
Roche
GE Healthcare
Thermo Fisher Scientific
Perkinelmer
Qiagen
Agilent Technologies
Veritas
BGI Group
Annoroad

Please note: The report will take approximately 2 business days to prepare and deliver.